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The G Protein-Coupled Receptor, GPR3, Promotes the Acquisition of Oocyte Meiotic 
Competence 
 
Laura D’Angelo Firmani, PhD 
University of Connecticut, 2018 
 
Mammalian oocytes are arrested in meiotic prophase from around the time of birth until 
just before ovulation. Following an extended period of growth, they are stimulated to mature to 
the metaphase II stage by a preovulatory luteinizing hormone (LH) surge that occurs with each 
reproductive cycle. Small, growing oocytes are not competent to mature into fertilizable eggs 
because they do not possess adequate amounts of cell cycle regulatory proteins, particularly 
cyclin-dependent kinase 1 (CDK1). As oocytes grow, they synthesize CDK1 and acquire the 
ability to mature. After oocytes achieve meiotic competence, meiotic arrest at the prophase stage 
is dependent on high levels of cAMP that are generated in the oocyte under the control of the 
constitutively active Gs-coupled receptor, GPR3. This dissertation examines the events occurring 
during the switch between GPR3-independent and GPR3-dependent meiotic arrest. We found 
that the ability of oocytes to mature, as well as oocyte CDK1 levels, were dependent on follicle 
size, but CDK1 expression in oocytes from preantral follicles was not acutely altered by the 
activity of follicle stimulating hormone (FSH). Gpr3 was expressed and active in incompetent 
oocytes within early stage follicles, well before cAMP is required to maintain meiotic arrest. 
Oocytes from Gpr3-/- mice were less competent to mature than oocytes from Gpr3+/+ mice, as 
assessed by the time course of germinal vesicle breakdown. Correspondingly, Gpr3-/- oocytes 
contained significantly lower CDK1 levels than their Gpr3+/+ counterparts that were at the same 
stage of follicle development. These results demonstrate that cAMP in oocytes promotes meiotic 
competence, through the activity of GPR3.
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I. Regulation of Meiosis in Mammalian Oocytes and Eggs 
 The female sex cell, the oocyte, proceeds through meiosis to reduce the number of 
homologous chromosomes to become haploid, allowing it to combine with the haploid genome 
of sperm at fertilization to form a diploid embryo. In fetal development in humans, around the 
twenty-fourth week of gestation, oocytes have entered meiosis and become arrested at the 
diplotene stage of prophase I until reproductive maturity, which can last months in mice and 
years in humans (Eppig et al. 2004; Gougeon 2004). With the onset of puberty, during the 
menstrual cycle, oocytes are stimulated by a preovulatory surge of luteinizing hormone (LH) to 
resume meiosis, mature into eggs, and to be ovulated into the fallopian tubes (Figure 1.1). 
Oocytes proceed through meiosis and become arrested for a second time at metaphase II 
(Mehlmann 2005a). Ovulated metaphase II eggs will complete meiosis in response to 
fertilization. 
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Figure 1.1. Meiotic events occurring in the oocyte and egg leading up to embryonic 
development. Individual granulosa cells are not defined but represented by the pink coloring in 
the follicle. GVI = Germinal Vesicle Intact, GVBD = Germinal Vesicle Break Down, LH = 
Luteinizing Hormone. 
 
The Oocyte is Maintained at Prophase I Arrest during Folliculogenesis 
 In the ovary, the oocyte is surrounded by one or more layers of granulosa cells to form 
the ovarian follicle, the functional unit of the ovary (Gougeon 1996). Initially, one layer of 
squamous pre-granulosa cells encircles the oocyte, forming primordial follicles. Generation of 
primordial follicles occurs between the sixth to ninth month of fetal life (Erickson 2008). Soon 
after the formation of the primordial follicle, folliculogenesis begins. Once a primordial follicle 
is activated to grow, the granulosa cells begin to change shape from squamous to cuboidal to 
form the primary follicle (Gougeon and Chainy 1987). Granulosa cells then begin to proliferate 
to form several more layers around the oocyte, developing into a secondary, preantral follicle. 
After the preantral follicle contains multiple layers of granulosa cells, a fluid-filled cavity begins 
to form, known as the antrum. This is characterized by the accumulation of follicular fluid 
between the granulosa cells, forming tertiary, early antral follicles. In humans, only one follicle 
within the population of early antral follicles in the ovary will achieve dominance over all the 
others and mature into a larger preovulatory, or Graafian, follicle in response to follicle-
stimulating hormone (FSH) (Erickson 2008; Gougeon 1996). These follicles consist of about 2-3 
layers of inner granulosa cells surrounding the oocyte, called cumulus cells, and about 5-10 
layers of outer granulosa cells, called mural granulosa cells (Jaffe and Egbert 2017). The 
enlarged antrum is found between these two types of granulosa cells.  
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 The development of follicles up to early antral follicles is relatively independent of the 
pituitary gonadotropins FSH and LH (Gougeon 2004), although preantral follicles possess FSH 
receptors, but not LH receptors (Abel et al. 2000; Hardy et al. 2017). The responsiveness of early 
antral follicles to FSH allows them the grow into preovulatory follicles which express LH 
receptors on their outermost mural granulosa cells (Bortolussi, Marini, Dal Lago 1977). As the 
follicle progresses through these different developmental stages, the oocyte is continuously held 
in prophase arrest. Only once LH stimulates preovulatory follicles, do the oocytes resume 
meiosis and ovulate.  
High Levels of Oocyte cAMP Generated by GPR3 Maintains Prophase I Arrest 
 In culture, releasing oocytes from antral follicles results in spontaneous meiotic 
resumption, indicated by germinal vesicle breakdown (GVBD). It was discovered that elevating 
3’,5’-cyclic AMP (cAMP) in oocytes from antral follicles by using a membrane-permeant, 
hydrolysis-resistant form of cAMP, or an inhibitor to cAMP phosphodiesterase, kept oocytes in 
arrest, revealing that cAMP is necessary to inhibit meiotic resumption (Cho, Stern, Biggers 1974; 
Magnusson and Hillensjo 1977). Initially, it was thought that within large antral follicles, cAMP 
was being generated in the granulosa cells and diffusing to the oocyte (Bornslaeger and Schultz 
1985; Dekel, Aberdam, Sherizly 1984; Dekel 2005; Edry, Sela-Abramovich, Dekel 2006). 
However, with studies using microinjection in follicle-enclosed oocytes, it was shown that the 
oocyte itself can generate cAMP.  
 Earlier experiments conducted by injecting an inhibitory antibody against Gs, or a 
dominant-negative form of Gs, into oocytes resulted in meiotic resumption (Kalinowski et al. 
2004; Mehlmann, Jones, Jaffe 2002). This indicated that Gs activity within the oocyte is 
indispensable to keeping the oocyte in arrest. Gs stimulates adenylyl cyclase to covert ATP into 
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the cAMP needed for arrest. It was also found that Gs is activated by the orphan G protein-
coupled receptor, GPR3 (Hinckley et al. 2005; Ledent et al. 2005; Mehlmann et al. 2004). 
Studies showed oocytes spontaneously resume meiosis, independent of LH, in preovulatory 
follicles of Gpr3-/- mice (Ledent et al. 2005; Mehlmann et al. 2004). The constitutively active 
GPR3 produces cAMP by particularly activating adenylyl cyclase type 3 (Figure 1.2) (Horner et 
al. 2003). 
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Figure 1.2. Different signaling events occurring during meiotic arrest and resumption in 
response to LH. The top of the figure is a simplistic view of Figure 1.1 to better understand 
when these signaling events are occurring in the oocyte respective to oocyte and follicle 
development.   
 
 High cAMP levels, associated with meiotic arrest, bind to and activate protein kinase A 
(PKA) to ultimately phosphorylate and inactivate the maturation promoting factor (MPF) 
(Figure 1.2) (Bornslaeger, Mattei, Schultz 1986; Holt, Lane, Jones 2013a). MPF is a 
heterodimer consisting of cyclin-dependent kinase 1 (CDK1) (also known as p34cdc2) and Cyclin 
B (Hunt 1989). Through multiple steps, PKA phosphorylates and activates the kinases 
WEE1B/MYT1, that then phosphorylates Thr14 and Tyr15 sites of CDK1 to inhibit its activity 
(Figure 1.2) (Duckworth, Weaver, Ruderman 2002; Han et al. 2005; Mueller et al. 1995). To 
ensure CDK1 remains in a phosphorylated state, PKA also phosphorylates the phosphatase 
CDC25B to keep it inactive and unable to dephosphorylate CDK1. The phosphorylated CDC25B 
associates with the 14-3-3 protein that keeps it sequestered in the cytoplasm and unable to 
translocate into the nucleus where phosphorylated CDK1 resides (Figure 1.2) (Duckworth, 
Weaver, Ruderman 2002; Pirino, Wescott, Donovan 2009). Restricting CDK1 activity prevents 
chromosome condensation and nuclear envelope break-down, also known as germinal vesicle 
breakdown (GVBD), that occurs during meiotic resumption (Figure 1.2) (Jaffe and Egbert 
2017).  
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The Production of cGMP in the Granulosa Cells Contributes to Prophase I Arrest 
 The follicle cells have a major role in keeping the oocyte in meiotic arrest. Isolating 
oocytes from antral follicles results in a decrease in oocyte cAMP and subsequent resumption of 
meiosis (Schultz, Montgomery, Belanoff 1983; Vivarelli et al. 1983). It has been found that the 
granulosa cells generate cGMP, which diffuses through gap junctions to the oocyte. In the 
oocyte, cGMP inhibits the cAMP phosphodiesterase type 3A (PDE3A) to prevent the hydrolysis 
of cAMP and maintain meiotic arrest (Figure 1.2). Also, knocking out PDE3A, or incubating 
isolated oocytes with milrinone, a PDE3A inhibitor, prevents meiotic resumption (Masciarelli et 
al. 2004; Shitsukawa et al. 2001). Therefore, limiting the activation of PDE3A either by cGMP 
in the follicle, or by milrinone in culture, keeps cAMP levels in the oocyte elevated, preserving 
prophase arrest.  
Luteinizing Hormone Stimulates Meiotic Resumption by Decreasing cGMP Levels 
 During the estrous cycle in mice, and presumably during the menstrual cycle in women, 
LH is released from the anterior pituitary to act on the LH receptors present on mural granulosa 
cells of the preovulatory follicle. Activated LH receptors cause a decrease in cGMP in the 
outermost granulosa cells, which provides a sink for cGMP to diffuse out of the oocyte 
(Shuhaibar et al. 2015). PDE3A becomes activated due to low oocyte cGMP levels, and 
hydrolyzes cAMP, lowering oocyte cAMP levels (Norris et al. 2009; Vaccari et al. 2009). This 
leads to a decrease in PKA activity and an increase in CDC25B activity; both contribute to 
dephosphorylating and activating MPF, resulting in oocyte meiotic resumption (Figure 1.2). 
During this phase of meiotic resumption, the oocyte undergoes meiotic maturation to become a 
metaphase II arrested egg, which will be ovulated for fertilization. Oocyte maturation is 
characterized by many events, including GVBD and the production of a polar body.  
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II. The Acquisition of Oocyte Meiotic Competence: Events Leading Up to the cAMP-   
dependent Arrest of Meiotic Prophase 
Oocyte Growth in the Ovary 
 In conjunction with follicle growth, the prophase I arrested oocyte also goes through a 
period of growth accompanied by the synthesis and accumulation of macromolecules and 
organelles (Sorensen and Wassarman 1976a; Szybek 1972). In mice, as well as other mammals, 
oocytes within preovulatory antral follicles are fully-grown and reach a diameter of 
approximately 80 m. Essentially all oocytes of this size are able to resume meiosis, either in 
vivo after the LH surge or spontaneously after release from their follicle in vitro. This is 
indicated by chromosome condensation, GVBD, and progression to metaphase II (Abe et al. 
2011). Contrary to fully-grown oocytes, growing oocytes that are less than 60 m in diameter, 
found within preantral follicles, fail to undergo GVBD under the same conditions and maintain 
an intact germinal vesicle (GVI) (Sorensen and Wassarman 1976a). This acquired ability to 
resume meiosis is called the acquisition of meiotic competence and coincides with the formation 
of the antrum in the follicle (Figure 1.1) (Erickson and Sorensen 1974; Mehlmann 2005a; 
Sorensen and Wassarman 1976a; Szybek 1972).  
Maturation Promoting Factor (MPF) During Oocyte Growth 
 It is evident that the preovulatory follicle is vital in keeping the fully-grown oocyte in 
meiotic arrest by keeping intracellular cAMP levels elevated in the oocyte. However, early 
follicle development, growing oocytes can maintain prophase I arrest themselves and do not rely 
on signals from the surrounding follicle or the contribution of cyclic nucleotides. This is due to 
the oocyte being meiotically incompetent and lacking the possession of cell cycle machinery, 
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such as CDK1 (Adhikari et al. 2012; Chesnel and Eppig 1995a; de Vantery et al. 1997; 
Nishimura et al. 2009) (Figure 1.3). Adequate amounts of dephosphorylated CDK1 are needed 
for the progression from prophase to metaphase in response to LH (Chesnel and Eppig 1995a; de 
Vant'ery et al. 1996; Kanatsu-Shinohara, Schultz, Kopf 2000; Mitra and Schultz 1996). The 
kinase activity of CDK1 assists in the disassembly of nuclear lamins and nuclear pores 
contributing to the nuclear envelope breakdown (GVBD) associated with meiotic resumption 
(Abe et al. 2011; Adhikari et al. 2012; Lenart et al. 2003). Therefore, small growing oocytes do 
not contain enough CDK1 to carry out these meiotic events. 
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Figure 1.3. Cell cycle protein expression and regulation during oocyte growth. The top of 
the figure is a simplistic view of Figure 1.1 to better understand when these signaling events are 
occurring in the oocyte respective to oocyte and follicle development. Bold protein names in 
purple represent increased protein expression for that particular protein. The nucleus in light gray 
is shown to demonstrate the localization of proteins. Evaluating if GPR3 is active in growing 
follicles is one aim for this dissertation, indicated by the question mark. Overall, this figure 
demonstrates changes in protein expression levels, phosphorylation states, MPF complex 
assembly, and localization of proteins in relation to the acquisition of meiotic competence. 
 Several studies have demonstrated that even though the concentration of Cyclin B 
remains moderately constant, the concentration of CDK1 increases significantly from meiotically 
incompetent to competent oocytes (Chesnel and Eppig 1995a; de Vant'ery et al. 1996; Kanatsu-
Shinohara, Schultz, Kopf 2000; Mitra and Schultz 1996) (Figure 1.3). It is proposed the CDK1 
could be a limiting factor in meiotically incompetent oocytes and that the accumulation of this 
protein is critical for the acquisition of meiotic competence. Along with total amounts of CDK1, 
the ability of CDK1 to dimerize with Cyclin B can occur during oocyte growth and competence 
(Figure 1.3). Early experiments injected CDK1 into incompetent oocytes, and even though 
CDK1 protein levels increased, they were still unable to resume meiosis (de Vantery et al. 1997). 
It was found that the newly synthesized CDK1 was dephosphorylated and unable to associate 
with Cyclin B (de Vantery et al. 1997). This suggests that an accumulation of CDK1 alone is not 
sufficient to establish oocyte competence and that there has to be a posttranslational modification 
that must occur during the acquisition of meiotic competence.    
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 Another event that takes place during the acquisition of meiotic competence is changes in 
the ability of the CDK1-Cyclin B complex, also known as MPF, to localize to the nucleus 
(Figure 1.3). In incompetent oocytes, both CDK1 and Cyclin B are found in the cytoplasm and 
move to the nucleus upon gaining meiotic competence (Mitra and Schultz 1996). This change is 
thought to be due to the phosphorylation state of Cyclin B, as phosphorylated Cyclin B is unable 
to associate with the nuclear export factor CRM1, keeping it in the nucleus (Yang et al. 1998). In 
agreement with this study, it was found that there is an increase in phosphorylated Cyclin B 
during the acquisition of meiotic competence (Kanatsu-Shinohara, Schultz, Kopf 2000). 
 Studies have also been conducted to analyze regulators of MPF during the acquisition of 
meiotic competence. In particular, the kinases WEE1 and CDC25, that inactivate and activate 
MPF, respectively, present in both incompetent and competent oocytes, and are always at a 
greater concentration than MPF (Figure 1.3). However, WEE1 levels decrease and CDC25 
levels increase during the acquisition of meiotic competence, suggesting a shift to priming the 
oocyte for MPF activation at the end of oocyte growth (Kanatsu-Shinohara, Schultz, Kopf 2000; 
Nakajo et al. 2000). Overall, several events in relation to MPF occur during the acquisition of 
meiotic competence such as changes in the concentration, phosphorylation state, complex 
assembly, localization, and regulation.  
cAMP Participates in the Acquisition of Meiotic Competence 
In addition to contributing to meiotic arrest, cAMP also appears to potentiate the 
acquisition of meiotic competence in growing oocytes. In these previous studies, denuded 
incompetent mouse oocytes were incubated in dbcAMP, a cell permeable analog of cAMP, or 
with forskolin, an activator of adenylyl cyclase, for 3 days. Both dbcAMP and forskolin 
promoted the acquisition of meiotic competence in a dose dependent manner, suggesting that 
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elevated levels of cAMP allow a growing oocyte to become more meiotically competent 
(Carroll, Whittingham, Wood 1991; Chesnel, Wigglesworth, Eppig 1994). In agreement with 
these findings, meiotic competence is compromised in oocytes that cannot generate cAMP 
(Ledent et al. 2005). These findings suggest a role of cAMP in early oocyte development. 
 
III. Improving Embryonic Developmental Competence 
 Proper and sequential events must occur during oocyte growth, acquisition of meiotic 
competence, resumption of meiosis, cytoplasmic maturation, and fertilization to ensure 
successful embryo development (Figure 1.1). During the acquisition of meiotic competence, as 
the oocyte grows, cytoplasmic organelles replicate, proteins are translated, and RNAs needed for 
development after fertilization are stored, contributing to a more developmentally competent 
embryo (Sorensen and Wassarman 1976b). Poor oocyte quality, with low developmental 
competence, impacts embryo survival before and after implantation, resulting in loss of 
pregnancy (Reader, Stanton, Juengel 2017). Even though sperm is an important component to 
fertilization, many of the cellular and molecular mechanisms required for early embryo 
development are inherent to the oocyte and egg (Swain and Pool 2008). Overall, insufficient 
oocyte growth and maturation lead to a less developmentally competent embryo.  
Assisted Reproductive Technologies (ART) 
 By researching and defining the molecular and cellular aspects between high and low-
quality oocytes and eggs, it can be better understood what factors have an impact on reproductive 
health, such as genetic mutations, cancer treatments, aging, and other environmental factors. 
Also, knowing markers for high oocyte and egg quality can assist in establishing better in vitro 
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culture systems to improve assisted reproductive technologies (ART). Even though ART is 
widely used to overcome infertility, the success rates are still relatively low. According to the 
Society for Assisted Reproductive Technologies (SART), in 2015, the live birth rate from an 
average of 1.17 embryos transferred per women under the age of 35 years was 48.2% per egg-
retrieval cycle (www.sart.org). Therefore, researching the components of a healthy, high-quality, 
developmentally competent oocyte due to proper acquisition of meiotic competence will allow 
for potential improvements in the success of both natural fertility and ART.     
Dissertation Aims 
 It is evident that the progression of a small growing oocyte into an MII egg encompasses 
many meiotic events essential for proper embryo development. I set out to determine the 
acquisition of oocyte meiotic competence within the same ovary, in respect to follicle size. The 
follicle is a functional structure with the oocyte directly coupled to the granulosa cells, and the 
granulosa cells coupled to each other by gap junctions. Connections between granulosa cells and 
the oocyte start during the very early stages of follicle formation and continues through 
folliculogenesis (Mitchell and Burghardt 1986). These gap junctions are vital for the transport of 
amino acids, glucose metabolites, nucleotides, and signaling molecules to the growing oocyte to 
ensure proper development (Bruzzone, White, Paul 1996). Also, prior to being responsive to 
extraovarian factors, such as pituitary gonadotropins, preantral follicle growth is dependent on 
gap junction communication, in addition to autrocrine and paracrine factors (Halpin et al. 1986). 
Studies have demonstrated the role of connexins, as components of gap junctions, in regulating 
both follicle growth and oocyte meiotic competence. Knockout mouse models for both connexin-
37 and connexin-43 showed an impaired ability to form follicles beyond the preantral stage and 
the follicles contain many meiotically incompetent oocytes (Ackert et al. 2001; Carabatsos et al. 
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2000). This demonstrates that communication between oocytes and granulosa cells during 
folliculogenesis needs to be intact for appropriate follicle and oocyte development and that gap 
junctions are required to coordinate oocyte meiotic competence. Investigating oocyte meiotic 
competence, in relation to follicle size, will show if there is a correlation between different stages 
in folliculogenesis and oocyte meiotic competence.  
Previous studies were conducted to analyze the acquisition of meiotic competence; 
however, mice of different ages were used and the follicle size was not carefully distinguished 
(Hirao, Miyano, Kato 1993; Szybek 1972; Wassarman and Josefowicz 1978). As previously 
mentioned, CDK1 activity has many meiotic functions, as such the breakdown of the nuclear 
envelope, suggesting it may be a critical factor in the acquisition of meiotic competence. Studies 
have established that CDK1 contributes to meiotic competence in mouse oocytes; however, they 
never systematically looked at CDK1 expression in relation to follicle development (Chesnel and 
Eppig 1995a; de Vant'ery et al. 1996; Kanatsu-Shinohara, Schultz, Kopf 2000). It remains to be 
known if the expression of oocyte CDK1 can be coordinated with a particular follicle stage. This 
would establish a better understanding of how follicle development can relate to a differential 
expression of cell cycle proteins within the oocyte.  
 By developing a systematic approach to carefully distinguish follicles of different 
developmental stages, it can be further analyzed how oocytes within small, preantral follicles 
respond to external stimuli. Even though it is well established that FSH promotes follicle growth, 
it is uncertain if it can contribute to oocyte-specific molecular changes associated with the 
acquisition of meiotic competence. Also, even though it has been well demonstrated that the 
oocyte can intrinsically generate cAMP by GPR3, some studies suggest that FSH causes an 
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increase in cAMP that diffuses through gap junctions to the oocyte (Webb et al. 2002a). It is 
unknown if this increase of cAMP has any effect on meiotic competence.  
 Understanding the molecular basis of the acquisition of meiotic competence, in respect to 
follicle size, can provide insight into the role of GPR3 early in oocyte growth. Even though 
GPR3 is a vital factor in keeping the fully-grown oocyte in a cAMP-dependent arrest, it is still 
uncertain if GPR3 has a role in oocytes earlier in development. Studies have suggested that 
GPR3 may be active in oocytes of preantral follicles (Freudzon et al. 2005; Hinckley et al. 2005; 
Vaccari et al. 2008); however, it is still unknown exactly when the GPR3 system becomes active. 
Also, it has been shown that cAMP may potentiate the acquisition of meiotic competence 
(Carroll, Whittingham, Wood 1991; Chesnel, Wigglesworth, Eppig 1994); however, the source 
of cAMP and its role in small, incompetent oocytes has yet to be established.  
 The overall goals of this dissertation are to correlate oocyte meiotic competence with 
follicle development to better understand meiotic events in relation to folliculogenesis. In 
particular, to analyze the cell cycle protein, CDK1, in relation to follicle size. Secondly, this 
dissertation will investigate the role of GPR3 in early oocyte development and in the 
acquisition of oocyte meiotic competence. 
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-CHAPTER 2- 
 
Materials and Methods 
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Media and Reagents 
Unless otherwise noted, all reagents were from Sigma Aldrich (St. Louis, MO). In most 
cases, the medium used for oocyte and follicle isolation was MEM (Life Technologies, 
Carlsbad, CA) supplemented with 20 mM HEPES, 75 g/ml penicillin G, 50 g/ml 
streptomycin, 0.1% polyvinyl alcohol (PVA), and 10 M milrinone. For experiments in which 
we cultured follicles with follicle stimulating hormone (FSH), we used bicarbonate-buffered 
MEM (Mehlmann 2005b) supplemented with 5% fetal bovine serum (FBS; see below). For 
experiments in which we treated oocytes with dbcAMP, follicles were isolated in HEPES-
buffered MEM containing 10 M milrinone, and oocytes were removed and cultured overnight 
in CZB medium (Chatot et al. 1989) supplemented with 5% FBS, 10 M milrinone, and 250 M 
dbcAMP.  
Oocyte and Follicle Isolation and Culture 
23-26-day-old mice were used for most experiments. In a few cases, we also used 2-, 4-,  
8-, and 11-day-old mice. Gpr3-/- mice were generated as described previously (Mehlmann et al. 
2004) and the colony was maintained by breeding Gpr3+/- mice to generate Gpr3-/- and Gpr3+/+ 
mice for littermate controls. If littermates were not available, age-matched wild type C57Bl/6J 
mice were obtained from Jackson Labs (Bar Harbor, ME). Mice were genotyped as previously 
described (Mehlmann et al. 2004). Follicles were manually dissected from ovaries using 30-
gauge needles. Oocytes were removed from all isolated follicles by follicle puncture. Cumulus 
cells were removed by repeated pipetting through a small-bore pipet.   
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For experiments in which follicles of different sizes were used, follicles were measured 
using a calibrated ocular reticle. Oocytes were released from the follicles by tearing a slit on one 
side. For the time course experiments, follicles were isolated from ovaries in medium containing 
10 M milrinone to prevent germinal vesicle breakdown (GVBD), were grouped according to 
size, and the oocytes were removed from the follicles. The cumulus cells were removed and the 
isolated oocytes were then washed into fresh medium without milrinone to initiate meiotic 
resumption. Oocytes were scored hourly using a Zeiss Discovery V8 stereomicroscope for 
GVBD. Isolated oocytes were imaged using a 40X 1.2 NA lens and oocyte diameters were 
measured using ImageJ (NIH).  
For experiments in which follicles were cultured with or without FSH, we isolated 
preantral follicles in bicarbonate-buffered MEMwithout milrinone (Mehlmann 2005b) and 
plated them individually on Millicell membranes (Millipore, Billerica, MA), plating a maximum 
of 20 follicles per Millicell. Half the follicles were incubated in medium containing 30 ng/ml 
ovine FSH (from A. F. Parlow, National Hormone and Peptide Program, Torrance, CA). Oocytes 
were removed from follicles following a 20 hr incubation period. Only GV-intact oocytes within 
undamaged follicles were utilized for experiments.  
Western Blotting 
Oocytes were obtained from follicles of defined sizes, cumulus cells were removed, and 
oocytes were transferred to microfuge tubes in a small volume of medium. 15 l of 1X sample 
buffer (Laemmli 1970) containing 5% -mercaptoethanol was added to each tube, samples were 
boiled for 5 minutes, and the whole volume was loaded into a 4-20% polyacrylamide gel 
(BioRad). Separated proteins were electrophoretically transferred onto nitrocellulose membranes 
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and the membranes were blocked in 1% non-fat dry milk in TBST. Primary antibody (anti-
CDK1 from Santa Cruz, catalog #sc-53219) was diluted to 2 g/ml and was incubated on the 
blot overnight at 4°C. Peroxidase-conjugated secondary antibody (Santa Cruz) was diluted 
1:5,000 in blocking buffer. Blots were developed using either ECL Prime (GE Healthcare, 
Chicago, IL) or WesternBright Sirius horseradish peroxidase substrate (Advansta, Menlo Park, 
CA), and imaged using a charge-coupled device camera (G:box Chemi XT4; Syngene). ImageJ 
software was used to perform the densitometry.  
Salmon-gal Staining 
Whole ovaries were dissected and were either cut into smaller pieces, or follicles were 
separated manually. In some cases, isolated oocytes were used. Salmon-gal staining was 
performed as previously described (Sundararajan et al. 2012). Briefly, ovaries, follicles, and 
isolated oocytes were fixed for 5 min in PBS containing 2% formalin, 0.2% glutaraldehyde, 5 
mM EGTA, 2 mM MgCl2, and 0.1% PVA, then were washed 3 times in rinse solution containing 
0.1% sodium deoxycholate, 0.2% Nonidet p40, and 2 mM MgCl2. After the rinses, follicles were 
stained using 1 mg/mL salmon-gal and 0.4 mM 4-nitro blue tetrazolium chloride (NBT) for 10-
20 minutes at 37°C. Two final washes of PBS with PVA were performed and all tissues were 
plated on Millicell culture plates (Millipore) and imaged using either a 10X, 0.3 N.A. or a 20X, 
0.5 N.A. lens. Photographs were taken using a Canon EOS M digital camera. Stained and 
unstained follicles, excluding the stroma outside the basement membrane, were measured using 
ImageJ.  
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cAMP Measurements  
Oocytes obtained from Gpr3+/+ and Gpr3-/- follicles that were ~140-180 m in diameter 
were isolated in medium containing milrinone and cleared of all cumulus cells using a small-bore 
mouth pipet. Oocytes were microinjected with the cAMP sensor protein, Epac2-camps300 
(Lowther, Nikolaev, Mehlmann 2011; Nikolaev et al. 2004; Norris et al. 2009), as previously 
described (Kline 2009; Norris et al. 2009), except that we used a final concentration in the oocyte 
of 2 M. Fluorescence was excited at 435 nm and was detected at 535/50 nm (YFP) and 480/40 
nm (CFP). Images were collected using a 40X 1.2 NA water immersion objective on a Zeiss 
Pascal confocal microscope. Following a scan in the presence of milrinone, milrinone was 
washed out of the medium and scans were performed 30 min after removing milrinone. YFP and 
CFP intensities were quantified within a circular fluorescent region of interest using the Zeiss 
Zen software. cAMP concentrations were calculated as described in Norris et al. (2009), using 
the standard curve that was generated by recording the basal YFP:CFP ratios before and after 
injecting cAMP to obtain the sensor maximum, and injecting PDE3A (to lower cAMP to a 
minimum level) to obtain the sensor minimum.  
RT-PCR 
Total RNA was extracted from isolated oocytes or whole ovaries using the RNeasy Plus 
Mini Kit (Qiagen, Venlo, Netherlands) according to the manufacturer’s instructions. RNA was 
reverse transcribed to cDNA using the iSCRIPT cDNA synthesis kit (Bio-Rad, Hercules, CA), 
using random primers. The following primer sets were used: Gpr3 forward 5’-
TATCCACTCTCCAAGAACCATCTGG-3’; Gpr3 reverse 5’-
GAATTAAGCCCTGGTGGACCTAAC-3’; Gapdh forward 5’-
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TGTTCCTACCCCCAATGTGT-3’; Gapdh reverse 5’-TGTGAGGGAGATGCTCAGTG-3’; 
Cdk1 forward 5’- GAACACCTTTCCCAAGTGGA-3’; Cdk1 reverse 5’- 
CCATTTTGCCAGAGATTCGT-3’; Rpl19 forward 5’-CGGGAATCCAAGAAGATTGA-3’; 
Rpl19 reverse 5’-TTCAGCTTGTGGATGTGCTC-3’. 
Cycling parameters for endpoint PCR (Gpr3 and Gapdh) were an initial denaturation at 
94°C for 5 minutes, followed by 35 cycles of 94°C for 45s, 60°C for 45s, 72°C for 90s, and a 
final extension at 72°C for 7 minutes. PCR products were electrophoresed on a 2% agarose gel 
and visualized using ethidium bromide (Bio-Rad, Hercules, CA), and imaged using the G:box. 
 Real-time qPCR (Cdk1 and Rpl19) was performed using a SYBR green kit, SsoFast 
EvaGreen Supermix (Bio-Rad, Hercules, CA) on a Bio-Rad CFX96 system (Bio-Rad, Hercules, 
CA). The cycling parameters included an initial denaturation at 95°C for 3 minutes, followed by 
50 cycles of 95°C for 10s and 55°C for 30s. A melt curve was performed, starting at 65°C and 
increasing by 0.5°C every 5s up to 95°C to determine primer specificity. Cdk1 gene expression 
was normalized to Rpl19 using the 2-ΔΔCt method.  
Statistical Analysis 
Statistical tests used for each experiment are described in the figure legends. GraphPad 
Prism6 was used for all statistical analyses.  
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-CHAPTER 3- 
 
The Switch from cAMP-independent to cAMP-dependent Arrest of Meiotic Prophase is 
Associated with Coordinated GPR3 and CDK1 Expression in Mouse Oocyte 
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INTRODUCTION 
Mammalian oocytes are arrested in meiotic prophase for most of a female’s reproductive 
lifespan and they remain arrested in prophase during a long period of oocyte and follicle growth. 
When follicles reach the preovulatory stage they become responsive to a surge in luteinizing 
hormone (LH) that occurs once per reproductive cycle. The LH surge signals the oocyte (via its 
action on follicle cells) to resume meiosis. Two mechanisms keep oocytes in meiotic arrest and 
prevent them from spontaneously resuming meiosis while in the ovary, one of which depends on 
cAMP and one that does not.  
Meiotically arrested mouse oocytes progressively increase in size from ~20 to ~75 m in 
diameter (Eppig and O'Brien 1996; Picton, Briggs, Gosden 1998). During most of this period of 
growth, prophase arrest is maintained because oocytes have not yet synthesized and accumulated 
mRNAs and proteins that are necessary for progression past prophase (Sorensen and Wassarman 
1976a). Once the oocyte becomes competent to mature, meiotic arrest becomes dependent on 
high levels of cAMP, which is generated by the constitutively active, Gs-coupled receptor, GPR3 
(Hinckley et al. 2005; Ledent et al. 2005; Mehlmann, Jones, Jaffe 2002; Mehlmann et al. 2004; 
Mehlmann 2005b). The elevated level of cAMP during meiotic arrest activates protein kinase A 
(PKA), which leads to the phosphorylation and inactivation of cyclin-dependent kinase 1 
(CDK1; also known as p34cdc2); the activation of CDK1 when cAMP levels are decreased is 
essential for meiotic resumption (Holt, Lane, Jones 2013b; Mehlmann 2005a; Mehlmann 2013). 
Cyclic AMP levels in the oocyte are kept high by cGMP contributed from the follicle cells; 
cGMP inhibits the activity of PDE3A, the phosphodiesterase in the oocyte that degrades cAMP 
when it is active (Mehlmann 2005a). If meiotically competent oocytes are isolated from follicle 
cells, cAMP levels decrease (Schultz, Montgomery, Belanoff 1983) and oocytes undergo 
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spontaneous GVBD (Edwards 1965); thus, both the oocyte and follicle cells contribute to cAMP-
dependent meiotic arrest.   
Oocytes reportedly achieve meiotic competence when they reach ~80% of their full-
grown size (>60 m) (Hirao, Miyano, Kato 1993; Szybek 1972; Wassarman and Josefowicz 
1978). This occurs concomitantly with folliculogenesis and coincides with the antrum formation 
in the follicle (Szybek 1972). CDK1, as well as its binding partner Cyclin B, are important for 
this process (Adhikari et al. 2012; Chesnel and Eppig 1995b). The relative and absolute amounts 
of CDK1 and Cyclin B protein have been measured, and both increase significantly during 
oocyte growth, whereas the relative amount of Cyclin B is always in excess of CDK1 (Chesnel 
and Eppig 1995b; de Vant'ery et al. 1996; Kanatsu-Shinohara, Schultz, Kopf 2000; Mitra and 
Schultz 1996); therefore, CDK1 is a limiting factor in the acquisition of meiotic competence. 
Thus far, CDK1 levels have only been measured in populations of oocytes removed from 10-12-
day-old ovaries compared with fully-grown oocytes removed from 6-week-old mice that had 
previously been injected with hormones to stimulate follicular growth. Meiotic competence is 
not solely dependent on CDK1 levels, however, because CDK1 levels increase in cultured small, 
nongrowing, incompetent oocytes without inducing meiotic maturation (Chesnel and Eppig 
1995b). In addition, overexpression of CDK1 in incompetent mouse oocytes is not sufficient to 
cause meiotic resumption (de Vantery et al. 1997). 
Because meiotic arrest begins in a cAMP-independent manner and progresses to GPR3 
(and therefore cAMP)- dependent arrest, there must be a switch in maintaining meiotic arrest, at 
some point, during oogenesis. No information exists as to when the GPR3 system turns on to 
achieve this switch. In addition to its established role in maintaining meiotic arrest in meiotically 
competent oocytes, there is evidence that cAMP promotes the acquisition of meiotic competence 
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in growing oocytes (Carroll, Whittingham, Wood 1991; Chesnel, Wigglesworth, Eppig 1994). 
This is based on experiments demonstrating that incompetent oocytes can acquire meiotic 
competence after being cultured in the presence of the cAMP analog, dbcAMP (Chesnel, 
Wigglesworth, Eppig 1994). However, whether cAMP is produced within the oocyte to 
contribute to the acquisition of meiotic competence, as well as the source of this cAMP in 
growing oocytes, has not been investigated.  
In this study, we examined the mechanisms of the acquisition of meiotic competence 
associated with the switch in meiotic regulation from cAMP-independent arrest to cAMP-
dependent arrest. In addition, because of the evidence that cAMP contributes to the acquisition of 
meiotic competence, and given that GPR3 is the receptor that stimulates cAMP production in 
oocytes, we investigated the potential role of GPR3 in the acquisition of meiotic competence. We 
found that CDK1 levels increase during the period when an oocyte becomes competent to 
resume meiosis. In addition, Gpr3 mRNA is expressed in incompetent oocytes very early on in 
follicle development and cAMP is generated prior to antral follicle development. Furthermore, 
the expression of Gpr3 appears to potentiate meiotic competence in oocytes that are at the stage 
where meiotic competence is usually achieved. The data presented here demonstrate that the 
switch to the GPR3 system occurs before cAMP is required to maintain meiotic arrest, thus 
ensuring that this system will be in place when it is required.  
RESULTS AND DISCUSSION 
Oocyte meiotic competence correlates with follicle size. 
To systematically study when oocytes acquire meiotic competence with respect to follicle 
development, we examined the time course of oocyte maturation, as indicated by GVBD, in 
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oocytes that were manually dissected from mouse ovaries and grouped according to follicle 
diameter. Previous studies examining the development of meiotic competence primarily utilized 
oocytes removed from ovaries of very young (~10-day-old) mice (Hirao, Miyano, Kato 1993; 
Szybek 1972; Wassarman and Josefowicz 1978). Although one study examined maturation rates 
in oocytes removed from defined follicle sizes (Erickson and Sorensen 1974), this study utilized 
follicles from sexually mature, cycling mice irrespective of the stage in the estrous cycle and 
they did not carefully distinguish early antral from antral follicles, which is the stage at which 
meiotic competence is thought to be attained (Chesnel, Wigglesworth, Eppig 1994; Mehlmann et 
al. 2004). Here, we used prepubertal mice (~23-27 days old) that were not yet cycling. We 
considered follicles ~140-180 m in diameter to be at the preantral stage, follicles ~220-250 m 
in diameter to be at the early antral stage, and follicles ≥290 m in diameter to be at the antral 
stage. After follicle isolation, oocytes were removed and scored every hour for GBVD, for up to 
5 hrs. 
As expected, nearly all of the oocytes retrieved from antral follicles underwent GVBD 
within 2 hrs after isolation (Fig. 3.1). Similar rates of GVBD were observed in oocytes retrieved 
from the 220-250 m follicle group. In contrast, we only observed ~40% GVBD in oocytes 
obtained from preantral stage follicles after 5 hrs. We found that 30% of oocytes removed from 
follicles 220-250 m in diameter had undergone GVBD at the time of follicle isolation, whereas 
none of the oocytes removed from the ≥290 m group had undergone GVBD at the time of 
follicle isolation. This is likely because some of the 220-250 m follicles were atretic since we 
did not prime the mice with PMSG before follicle isolation; hormonal priming would be 
expected to rescue such follicles destined for atresia. Atretic follicles often contain oocytes that 
have undergone GVBD (Gougeon and Testart 1986). 
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Figure 3.1. Analyzing meiotic resumption in oocytes from preantral, early antral, and 
antral follicles. GVBD time course using oocytes isolated from follicles of different size ranges. 
The graph demonstrates that oocytes become meiotically competent within follicles ~220-250 
m in diameter. 
 
Because the ability to mature has been linked to oocyte size, we measured oocyte 
diameters in oocytes retrieved from preantral and antral follicles. The average diameter of 
preantral oocytes was significantly smaller than antral oocytes (71 ± 0.4 m vs 74 ± 0.3 m 
respectively), and the percentage of preantral oocytes that underwent GVBD in our study was 
lower than that reported by Hirao et al. (1993), who found that 90% of oocytes 65-70 m in 
diameter underwent GVBD in culture conditions similar to those used in our study. This 
discrepancy is likely due to the length of time in culture, as we only monitored GVBD for 5 hrs, 
whereas Hirao et al. (1993) examined oocytes after they had been cultured for 24 hrs. Previous 
studies have shown that oocytes within ovaries of  ≥15-day old mice can undergo spontaneous 
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GVBD when removed from ovaries (Sorensen and Wassarman 1976a; Wickramasinghe, Ebert, 
Albertini 1991a). However, these previous studies retrieved oocytes from ovaries irrespective of 
follicle size. Our study systematically correlates GVBD competence with follicle size, and the 
results clearly show that oocytes acquire meiotic competence as follicles reach a diameter of 
~220 m.    
 
CDK1 levels increase in oocytes from the preantral to the antral follicle stage. 
Several previous studies have identified CDK1 as a key factor that contributes to the 
acquisition of meiotic competence in mouse oocytes (Chesnel and Eppig 1995b; de Vant'ery et 
al. 1996; Kanatsu-Shinohara, Schultz, Kopf 2000; Mitra and Schultz 1996). Levels of CDK1 
increase during oocyte growth, as determined by measuring proteins using western blots. 
However, in these previous studies, CDK1 measurements were done using oocytes removed 
from 10-12-day-old ovaries compared with fully-grown oocytes removed from 6-week-old, 
hormonally-primed ovaries. To determine if CDK1 levels increase during the period of oocyte 
growth from the preantral to the antral stage, we isolated follicles of different sizes from the 
same ovaries, grouped the follicles according to size, removed the oocytes, and performed 
western blots for CDK1. In an initial experiment, we ran a CDK1 blot using defined numbers of 
fully-grown oocytes to estimate the number of oocytes to use for subsequent experiments and to 
confirm the linearity of our western blotting detection method (Fig. 3.2A). We found that our 
CDK1 antibody produced a clean band and the signal increased linearly. We observed a strong 
band using 25-50 oocytes, so unless noted, we used 30 oocytes per lane in subsequent 
experiments. The amount of CDK1 increased significantly in oocytes during the period from the 
preantral to the antral stage, particularly from the preantral to the early antral stage (Fig. 3.2B,C). 
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This increase was not due solely to an increase in oocyte volume which also occurred during the 
period of follicle growth, because the amount of CDK1 increased approximately 2-fold, whereas 
the oocyte volume increased only ~1.25-fold (Fig. 3.2D). This result correlates with the 
increased ability of oocytes within early antral follicles (220-250 m in diameter) to undergo 
GVBD, and supports the hypothesis that the level of CDK1 is important for the acquisition of 
meiotic competence.  
 
Figure 3.2. CDK1 levels increase in oocytes during the acquisition of meiotic competence. 
A) Defined numbers of full-grown, prophase arrested oocytes were probed for CDK1 with 
western blot to test the linearity of ECL signal. B) Western blot for CDK1 in oocytes isolated 
from follicles of defined diameters, from the same ovary. C) CDK1 densitometry, showing that 
the amount of CDK1 increases significantly in the 220-250 m group, which corresponds to the 
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time that oocytes acquire meiotic competence. Data were compiled from 6 independent 
experiments. Bars with different letters are significantly different (P<0.05). D) Volumes in 
oocytes retrieved from 140-180 m diameter follicles compared to ≥290 m diameter follicles. 
 
FSH does not acutely alter oocyte CDK1 levels. 
Follicle stimulating hormone (FSH) is essential for follicle growth, as follicle 
development past the preantral stage does not occur in FSH receptor-deficient mice (Abel et al. 
2000). Although follicle cells express RNA encoding FSH receptors in follicles as small as ~75 
m in diameter (Hardy et al. 2017), they generally start becoming responsive to FSH when they 
are ~130 m in diameter (Hardy et al. 2017). To investigate if this responsiveness to FSH can be 
a signal to stimulate CDK1 expression, we isolated oocytes from FSH-responsive, preantral stage 
follicles (140-180 m in diameter) after culturing follicles for ~24 hrs with or without FSH. We 
chose a 24 hr incubation period rather than a longer culture time to determine if FSH acutely 
regulates CDK1 expression. There was no difference in CDK1 levels in oocytes treated with 
FSH compared to untreated follicles (Fig. 3.3A). This result indicates that FSH does not acutely 
regulate CDK1 levels, but chronic stimulation probably contributes to CDK1 levels by 
stimulating follicle growth, which is associated with the acquisition of meiotic competence.  
FSH acts through the FSH receptor, a Gs-coupled receptor on the follicle cells, 
stimulating the production of cAMP (Hunzicker-Dunn and Mayo 2015; Simoni, Gromoll, 
Nieschlag 1997). A popular hypothesis for many years was that cAMP produced in follicle cells 
diffuses through gap junctions into the oocyte to elevate cAMP levels and inhibit premature 
meiotic resumption (Dekel 2005; Edry, Sela-Abramovich, Dekel 2006). Dekel et al. (1984) 
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demonstrated that elevated cAMP levels in cumulus cells in response to forskolin treatment was 
required to inhibit spontaneous GVBD in rat oocytes, suggesting that cAMP is produced in 
follicle cells and diffuses through gap junctions into the oocyte (Dekel, Aberdam, Sherizly 
1984). However, they did not measure cAMP levels in isolated oocytes following forskolin 
treatment. Likewise, inducing gap junction closure with carbenoxelone in follicle-enclosed 
oocytes causes GVBD in mouse and rat oocytes (Norris et al. 2009; Sela-Abramovich et al. 
2006), but no oocyte cAMP measurements were done before 45 minutes after treating follicles 
with carbenoxolone. Webb et al. (2002) showed that FSH stimulation of the cumulus cells causes 
a transient increase in cAMP in the oocyte (Webb et al. 2002b). However, this is a delayed 
response, not consistent with cAMP transfer through gap junctions. Finally, Li et al. (2012) 
demonstrated a relatively small increase in oocyte cAMP levels in response to treatment of 
cumulus-enclosed mouse oocytes with FSH, but the cAMP levels did not equilibrate in cumulus 
cells and oocytes, which is inconsistent with cAMP diffusion through gap junctions (Li, Mao, 
Xia 2012). In any case, any cAMP increase that might occur in the oocyte in response to FSH 
stimulation of the cumulus cells did not affect CDK1 expression in the oocyte (Fig. 3.1F). 
Consistent with this conclusion, treating isolated oocytes obtained from 140-180 m follicles 
with dbcAMP for 20 hrs did not stimulate expression of CDK1 (Fig. 3.3B), indicating that 
cAMP does not acutely regulate CDK1 expression.   
 
33 
 
 
Figure 3.3. CDK1 levels are not acutely regulated by FSH or cAMP in oocytes from 
preantral follicles. For (A), oocytes from 140-180 m diameter follicles were cultured for 20 
hrs in medium with or without 30 ng/ml FSH and the blot was run after removing oocytes from 
follicles. For (B), isolated oocytes from 140-180 m diameter follicles were treated for 20 hrs 
with 250 M dbcAMP before running western blots. Significance was determined by Student’s 
t-test; P<0.05 was considered significant. Bars are mean ± SEM. 
 
 The constitutively active G-protein coupled receptor, Gpr3, is expressed in oocytes early in 
follicle development. 
Once meiotic competence has been achieved, arrest at the prophase stage becomes 
dependent on cAMP that is produced in oocytes through the constitutive activity of the Gs-
coupled receptor, GPR3 (Hinckley et al. 2005; Ledent et al. 2005; Mehlmann et al. 2004; 
Mehlmann 2005b). There is some evidence that GPR3 may be active in oocytes within preantral 
follicles (Freudzon et al. 2005; Hinckley et al. 2005; Vaccari et al. 2008), suggesting that the 
cAMP-producing system is functional before it is needed to maintain meiotic arrest; however, it 
has not been determined when Gpr3 expression begins. cAMP may also promote the acquisition 
of meiotic competence in mouse oocytes (Chesnel, Wigglesworth, Eppig 1994). We examined 
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when the Gpr3 promoter becomes active during follicle development using a Gpr3 knockout 
mouse in which the single exon of the Gpr3 gene was replaced with a lacZ cassette under the 
control of the Gpr3 promoter (Mehlmann et al. 2004; Tanaka et al. 2009). When the Gpr3 
promoter is active, the lacZ cassette stimulates the production of -galactosidase, the activity of 
which can be detected by staining with 6-chloro-3-indolyl--D-galactopyranoside (salmon-gal), 
a more sensitive substrate than the commonly used X-gal (Sundararajan et al. 2012). We stained 
whole ovaries and isolated follicles from 17-23-day-old Gpr3-/- mice and found that -
galactosidase was present in virtually all oocytes from preantral follicles, indicating active 
transcription of Gpr3 (Fig. 3.4A). -galactosidase was expressed only within the oocytes rather 
than the follicle cells, and staining was restricted to the GV, possibly due to a nuclear 
localization signal commonly associated with-galactosidase. As expected, Gpr3+/+ oocytes, 
which did not contain the lacZ cassette, did not stain when incubated with salmon-gal (Fig. 
3.4B).  
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Figure 3.4. Gpr3 mRNA is present in oocytes of all follicle sizes in 3-week-old mice. A,B) 
Salmon-gal staining in whole ovaries or in isolated follicles obtained from 3-week-old Gpr3-/- 
(A) or Gpr3+/+ (B) mice. The inset in (A) shows staining within the GV of an isolated oocyte. 
 
Because essentially all the oocytes in follicles from 3-week-old Gpr3-/- mice stained 
positive for  -galactosidase, we examined -galactosidase expression in 11-day-old Gpr3-/- mice 
to determine when the Gpr3 promoter becomes active. As in the older mice, almost all oocytes 
within small, preantral follicles stained, although we occasionally found an oocyte from the 
smallest follicles that did not stain (Fig. 3.5A).  We then tested even younger (8-day-old) Gpr3-/- 
mice and found that 61% (19/31) of oocytes within follicles from these mice were also positive 
for -galactosidase (Fig. 3.5B). We could not detect positive staining in ovaries from newborn 
(4-day-old) mice using salmon-gal (not shown). To confirm the absence of detectable Gpr3 
mRNA in newborns, we examined Gpr3 expression in the ovaries of 2-day-old mice using RT-
PCR. As shown in Fig. 3.5C, ovaries from four separate mice did not express detectable Gpr3, 
whereas 2 oocyte equivalents from a 25-day-old mouse showed a strong band positive for Gpr3. 
The newborn ovaries had similar or higher amounts of Gapdh compared to the oocytes from the 
25-day-old mouse. Because newborn ovaries only contain primordial follicles consisting of an 
oocyte surrounded by a single layer of squamous epithelial cells, the majority of the ovary is 
composed of oocytes rather than somatic cells. Therefore, the lack of Gpr3 signal in the newborn 
ovaries strongly suggests that Gpr3 is not expressed in mouse oocytes at this age.  
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Figure 3.5. Oocytes in small follicles and newborn ovaries lack Gpr3 mRNA expression.  
A,B) Salmon-gal staining in follicles from 11-day-old (A) and 8-day-old (B) Gpr3-/- mice. C) 
PCR amplifying Gpr3 in ovaries from four different 2-day-old mice (lanes 1-4). 2 oocytes from a 
25-day-old mouse (+) were used as a positive control for Gpr3. Gapdh was used a positive 
control for the newborn ovary cDNA.  
 
 
The average diameter of Gpr3-positive oocytes from 8-day-old mice was significantly 
greater than that of unstained oocytes (36 ± 1 m S.E.M., vs 27 ± 1 m). Likewise, follicles 
containing Gpr3-positive oocytes had significantly larger diameters than Gpr3-negative follicles 
(53 ± 1 m vs 45 ± 3 m). We did not observe any Gpr3-positive oocytes smaller than 31 m, 
while 75% (n=12) of the Gpr3-negative oocytes we measured were 30 m or smaller. Therefore, 
Gpr3 RNA starts to be expressed in oocytes when they are ~30 m in diameter. Due to the 
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unavailability of antibodies that can effectively detect endogenous GPR3 in mouse oocytes, we 
were unable to examine when GPR3 protein becomes expressed. 
This result demonstrates that oocytes express the machinery necessary to generate cAMP 
within small, growing oocytes. In newborn mouse ovaries, cAMP has been linked to meiotic 
progression to diplotene as well as the formation of primordial follicles (Wang et al. 2015). This 
study showed that cAMP levels increase significantly in mouse ovaries just before birth; cAMP 
controls the disassembly and degradation of synaptonemal complex protein 1 (SYCP1) in the 
oocyte, thereby permitting the oocyte to reach the dictyate stage of prophase. Inhibiting cAMP 
production in newborn ovaries causes an increase in SYCP1 and leads to a delay in meiotic 
prophase as well as a disruption in germline cyst breakdown and primordial follicle formation 
(Wang et al. 2015). The effects of cAMP at these early stages appear to be due to the activity of 
adenylate cyclase type 2 in the oocyte, whereas meiotic arrest in meiotically competent oocytes 
is due to the activity of adenylate cyclase type 3 (Horner et al. 2003). Because we could not 
detect Gpr3 in newborn ovaries using salmon-gal staining and PCR, it is unlikely that GPR3 
provides the source of cAMP in newborn ovaries. In addition, oocytes from Gpr3-/- mice clearly 
reach the diplotene stage and follicles form normally (this study; (Mehlmann et al. 2004), so it is 
likely that newborn oocytes produce cAMP through a different system. Our results demonstrate 
that Gpr3 is expressed in small, growing oocytes, suggesting that cAMP could be produced 
before the fully-grown stage, in which meiotic arrest at prophase depends on cAMP.  
 
GPR3 is active in oocytes from preantral follicles (140-180 m diameter) 
To confirm that GPR3 is functional in the oocytes within preantral follicles, we used a 
FRET-based assay to measure free cAMP in oocytes removed from follicles that were 140-180 
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m in diameter. We included milrinone in the culture medium to prevent phosphodiesterase 3A 
(PDE3A) activation during oocyte isolation, thus preventing cAMP hydrolysis. Isolated oocytes 
from Gpr3+/+ and Gpr3-/- mice were injected with a sensor (Epac2-camps300) consisting of the 
cAMP binding domain of EPAC2, fused to CFP and YFP (Lowther, Nikolaev, Mehlmann 2011; 
Nikolaev et al. 2004; Norris et al. 2009). FRET measurements showed significantly higher 
CFP/YFP fluorescence ratios in Gpr3+/+ oocytes compared to Gpr3-/- oocytes (Fig. 3.6A). These 
ratios corresponded to cAMP concentrations of ~700 nM vs ~300 nM, respectively (Fig. 3.6B). 
700 nM cAMP in Gpr3+/+ oocytes is similar to the ~660 nM that was reported in full-grown 
oocytes within antral follicles (Norris et al. 2009), using the same FRET sensor that we used 
here. When milrinone was washed out of the culture medium, the CFP/YFP fluorescence ratios 
decreased and cAMP levels in the Gpr3+/+ oocytes fell to ~100 nM within 30 min (Fig. 3.6). 
Cyclic AMP levels also fell to ~100 nM in the Gpr3-/- oocytes (Fig. 3.6B), although this 
observation was not statistically significant (p = 0.05). It was somewhat surprising that there was 
measurable cAMP in the Gpr3-/- oocytes. This suggests that another mechanism other than GPR3 
can contribute to cAMP production in the oocyte. This small amount of cAMP, however, is 
clearly not sufficient to maintain meiotic arrest, as the depletion of Gpr3-/- in oocytes renders 
them incapable of maintaining meiotic arrest (Mehlmann et al. 2004; Mehlmann 2005b). Overall, 
this result demonstrates that GPR3 is active in oocytes within small follicles, and shows that 
PDE3A is also present and capable of being activated in these oocytes.   
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Figure 3.6. GPR3 is active and stimulates cAMP production in oocytes from follicles that 
are 140-180 m in diameter. Measurement of cAMP concentrations in Gpr3-/- and Gpr3+/+ 
oocytes was performed using the Epac2-camps300 FRET sensor. cAMP concentrations were 
first measured in oocytes from follicles 140-180 m in diameter in the presence of the PDE3A 
inhibitor, milrinone, then milrinone was washed out, stimulating cAMP degradation, and cAMP 
was measured 30 min later. A) Data presented as ratios of CFP/YFP fluorescence. B) Data 
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presented as cAMP concentration. Bars are mean ± SEM and significance was determined by 
one-way ANOVA; P<0.05. Bars with different letters are significantly different. 
 
Fewer oocytes from Gpr3-/- mice are competent to mature than Gpr3+/+ oocytes. 
Two earlier studies showed that cAMP promotes the acquisition of meiotic competence. 
Both isolated as well as follicle-enclosed small, growing, incompetent oocytes become 
competent when cultured in the presence of dbcAMP (Carroll, Whittingham, Wood 1991; 
Chesnel, Wigglesworth, Eppig 1994).  As it has been found that oocytes within preantral follicles 
express Gpr3 and produce cAMP, our data are consistent with the possibility that GPR3 may 
contribute to the acquisition of meiotic competence. To examine this, we analyzed the time 
course of GVBD using Gpr3+/+ and Gpr3-/- oocytes removed from follicles of different sizes, as 
in the experiments described for Fig. 3.1. Fig. 3.7 shows that Gpr3-/- oocytes took longer to 
undergo GVBD, and fewer completed GVBD. The difference was particularly striking in oocytes 
retrieved from early antral follicles, the stage at which oocytes are beginning to acquire meiotic 
competence (Chesnel, Wigglesworth, Eppig 1994; Mehlmann et al. 2004). This result shows 
that, although Gpr3-/- oocytes eventually acquire the ability to undergo GVBD, they do so at a 
slower rate than their Gpr3+/+ counterparts.  
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Figure 3.7. Oocytes deficient in Gpr3 are slower to achieve meiotic competence than Gpr3+/+ 
oocytes. Time course of GVBD in Gpr3-/- and Gpr3+/+ oocytes removed from follicles of defined 
sizes. Gpr3+/+ data are the same as in Figure 3.1. Significance was determined using two-way 
analysis of variance after arc-sin transformation to normalize data. (P<0.05). 
 
That Gpr3-/- oocytes undergo GVBD at a slower rate than Gpr3+/+ oocytes is in 
agreement with results published by Ledent et al. (2005), who showed that fewer oocytes from 
3.5-week-old and 6-month old Gpr3-/- mice undergo GVBD and first polar body formation than 
Gpr3+/+ oocytes. The higher percentage of Gpr3-/- oocytes from ≥290 m follicles that 
underwent GVBD within 5 hrs in our study is likely due to the fact that Ledent et al. (2005) did 
not distinguish antral follicle sizes; rather, they obtained oocytes from all follicles ≥190 m in 
diameter (Ledent et al. 2005). It should also be noted that we saw ~20% GVBD at the time of 
isolation of Gpr3-/- oocytes from antral follicles. This value is much lower than the ~85-90% 
GVBD rate observed previously in Gpr3-/- antral follicles (Mehlmann et al. 2004), and also lower 
than the ~50% GVBD observed by Ledent et al. (2005). The difference could be due to hormonal 
priming; Mehlmann et al. (2004) and Ledent et al. (2005) primed mice with PMSG prior to 
collecting ovaries or isolating follicles, which yielded follicles ≥350 m in diameter, whereas 
here we used follicles from unprimed prepubertal mice that generally did not exceed 320 m in 
diameter, so follicle size could be a factor in our results. It is also possible that priming could 
cause the synthesis of other proteins that are important for meiotic competence. In addition, 
previous studies counted all antral follicles, including follicles that may have been atretic, 
whereas here we isolated only follicles that were clear and presumably not atretic. It might be 
expected that oocytes within atretic follicles are either GVBD or degenerated, which could be 
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reflected in the higher percentage of GVBD observed in the previous studies. Our results 
demonstrate that Gpr3-/- oocytes undergo GVBD at a slower rate even within follicles that are 
apparently healthy and viable.  
 
CDK1 levels increase in oocytes from Gpr3-/- oocytes but the levels are lower than in Gpr3+/+ 
oocytes.  
To examine if GPR3 activity could be associated with CDK1 levels, we isolated follicles 
of various sizes from ovaries of Gpr3-/- mice and grouped them according to size, as above. We 
removed oocytes from these follicles and compared the amount of CDK1 in oocytes using 
western blot. We found that, as in Gpr3+/+ oocytes, the amount of CDK1 increased during oocyte 
growth in Gpr3-/- oocytes (Fig. 3.8A,B). However, the amount of CDK1 was significantly lower 
in Gpr3-/- oocytes in the 140-180 m and 220-250 m groups. This difference was not due to 
differences in total protein among the Gpr3+/+ and Gpr3-/- groups, as probing blots for the highly 
expressed IP3 receptor showed no differences (Fig. 3.4C).  
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Figure 3.8. CDK1 protein expression is altered in Gpr3-/- oocytes of preantral and early 
antral follicles. A) Western blot for CDK1 in Gpr3-/- oocytes removed from follicles of defined 
diameters. B) The amount of CDK1 is significantly lower in oocytes retrieved from preantral and 
early antral follicles of Gpr3-/- mice compared with Gpr3+/+ mice. The Gpr3+/+ graph shown here 
is the same as in Figure 3.2. CDK1 amounts for Gpr3+/+ vs Gpr3-/- were compared by t-tests with 
the Holm-Sidak correction for multiple comparisons. *=P<0.03. C) IP3 receptor expression, as 
determined by western blot, in oocytes from both genotypes and removed from follicles of 
defined diameters was used as a loading control. 
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Cdk1 expression is regulated translationally during the acquisition of meiotic competence. 
It is not clear how the expression of GPR3 leads to a higher amount of CDK1 in Gpr3+/+ 
oocytes compared to Gp3-/- oocytes. The simplest explanation is that Gpr3+/+ oocytes contain 
more mRNA encoding CDK1 than Gpr3-/- oocytes. However, real-time PCR using oocytes 
retrieved from follicles of different sizes and from both genotypes showed that the levels of Cdk1 
RNA were similar in all groups (Fig. 3.9), indicating that increased transcription is unlikely to 
account for higher amounts of CDK1 protein in the Gpr3+/+ oocytes. Our results suggest that the 
increase in the amount of CDK1 protein during oocyte maturation occurs at the translational 
level. There is at least one example of cAMP increasing translation independently of stimulating 
gene transcription. Synthesis of tyrosine hydroxylase (TH) protein is stimulated by cAMP in 
midbrain dopaminergic neurons without an increase in mRNA levels (Chen et al. 2008). In these 
cells, cAMP treatment increases the association of TH mRNA with polysomes through proteins 
that bind to cis-acting sequences within the 3’UTR of the TH RNA (Chen et al. 2008; Xu, 
Sterling, Tank 2009). It is possible that cAMP has a similar stimulatory effect in oocytes, but this 
needs to be further examined. It is also possible that cAMP influences the expression or activity 
of an intermediate protein that can regulate CDK1 translation. 
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Figure 3.9. Cdk1 mRNA levels do not change between Gpr3+/+ and Gpr3-/- oocytes removed 
from follicles of defined diameters. RT-PCR was performed and all data was normalized to 
Rpl19. 
 
Conclusions 
This study shows that CDK1 levels increase in mouse oocytes as they progress from 
meiotically incompetent to meiotically competent stages, as follicles transition between preantral 
(140-180 m in diameter) and early antral (220-250 m in diameter) stages. Gpr3 is expressed 
and active early in oocyte development, prior to the acquisition of meiotic competence and 
subsequent dependence on cAMP for meiotic arrest. The presence and activity of GPR3 protein 
are likely to precede the synthesis of CDK1, but are not required for it. Our results suggest that 
the production of cAMP through GPR3 signaling early on in development potentiates the 
acquisition of meiotic competence in oocytes. In support of this, fewer Gpr3-/- oocytes within 
140-180 m diameter follicles underwent GVBD than oocytes containing an intact GPR3 
system. Lower amounts of CDK1 in Gpr3-/- oocytes could contribute to this decrease in meiotic 
competence observed in Gpr3-/- oocytes. Overall, these results indicate that GPR3 has a role in 
the acquisition of oocyte meiotic competence, but the mechanism through which it affects 
meiotic competence needs further study.   
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The research presented in this dissertation highlights key meiotic events that lead to 
proper acquisition of meiotic competence in relation to follicle development.  
 
The Switch from cAMP-independent to cAMP-dependent Arrest of Meiotic Prophase is 
Associated with Coordinated GPR3 and CDK1 Expression in Mouse Oocytes 
Conclusions  
Prior to being fully-grown, the incompetent growing oocyte is synthesizing and 
accumulating the necessary macromolecules and organelles termed the acquisition of meiotic 
competence (Sorensen and Wassarman 1976a). Proper coordination and presence of different 
factors during oocyte growth ensures that a high-quality oocyte will develop into a healthy 
embryo. This study set out to systematically analyze the when oocytes become meiotically 
competent, which was found to be around the time the mouse follicle is approximately 220 m in 
diameter which coincides with the beginning stages of the antrum forming. Furthermore, it was 
shown that oocyte CDK1 levels significantly increased as the follicle developed from a preantral 
to antral follicle, suggesting this cell cycle protein to be a key component in the acquisition of 
meiotic competence.  
Since preantral follicles could be responsive to FSH (Hardy et al. 2017), and since it was 
suggested that FSH can cause an increase in cAMP levels in the oocyte via gap junctions (Webb 
et al. 2002b), both FSH and dbcAMP were incubated with oocytes from preantral follicles to see 
if these components could induce the expression CDK1 resulting in a more competent oocyte. 
Neither FSH or dbcAMP caused any changes in CDK1 expression, indicating that these 
signaling molecules do not acutely regulate oocyte CDK1 levels.  
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Previous studies showed that GPR3 may be expressed in oocytes from preantral follicles 
(Freudzon et al. 2005; Hinckley et al. 2005; Vaccari et al. 2008). However, exactly when GPR3 
becomes expressed and if it is active in small incompetent oocytes remains to be determined. By 
using the -gal staining method, we showed that Gpr3 becomes expressed in mice between 4- to 
8-days old, as no staining was detected in 4-day old ovaries. PCR of ovaries from 2-day-old mice 
indicated that Gpr3 is not expressed in newborn ovaries, despite evidence that there is cAMP in 
the oocyte early in development. There may be other mediators present in the oocyte, besides 
GPR3, that generate cAMP through adenylate cyclase type 2 activation in newborn mice (Wang 
et al. 2015). Analyzing -gal staining in 8-day-old mice revealed that Gpr3 transcription starts to 
become active when the oocyte reaches approximately 30m in diameter. This demonstrates that 
the machinery to generate cAMP is expressed early in oocyte development and is present prior to 
the cAMP-dependent meiotic arrest in fully-grown oocytes. 
Knowing that Gpr3 is expressed early in oocyte development, we then investigated if the 
GPR3 protein was active in oocytes from preantral follicles. Using the FRET-based assay, we 
showed that Gpr3+/+ oocytes had normal cAMP levels around 700nM that fell to 100nM when 
milrinone was washed out of culture causing PDE3A activation. The conclusions from this are 
two-fold: it shows first that GPR3 is present and active in small oocytes; and second, that 
PDE3A can be activated during this oocyte stage as well. Additionally, we showed that Gpr3-/- 
had significantly lower cAMP levels, around 300nM, compared to Gpr3+/+, indicating that GPR3 
is the receptor responsible for generating cAMP at this oocyte developmental stage.  
Earlier studies showed that cAMP can promote the acquisition of meiotic competence 
(Carroll, Whittingham, Wood 1991; Chesnel, Wigglesworth, Eppig 1994). Knowing that GPR3 
is a receptor responsible for generating cAMP in incompetent oocytes, we looked for a possible 
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correlation between GPR3 expression and meiotic competence. We found that Gpr3-/- oocytes 
were less competent than Gpr3+/+ oocytes, especially at the follicle developmental stage when 
oocytes start to become meiotically competent. Further, CDK1 levels were significantly 
decreased in Gpr3-/- oocytes compared to Gpr3+/+; however, there was still CDK1 present, 
indicating that the mechanisms stimulating CDK1 expression may be delayed in Gpr3-/- oocytes. 
It can be observed that the Gpr3-/- oocytes from the 220-250m follicles had similar CDK1 
levels compared to Gpr3+/+ oocytes from the 140-180m follicles. Along with this finding, the 
GVBD time course data is very similar between Gpr3-/- oocytes from the 220-250m follicles 
and Gpr3+/+ oocytes from the 140-180m follicles. This indicates that the amount of CDK1 
strongly correlates with the ability to resume meiosis.  In all other follicle sizes, the RT-PCR 
results suggests that this difference in CDK1 expression between Gpr3+/+ and Gpr3-/- oocytes is 
regulated at the translational level.  
Lastly, during this study, Gpr3+/+ and Gpr3-/- oocytes of defined follicle sizes were 
analyzed for Gs expression by western blot. As reported previously, Gs levels were significantly 
higher in the Gpr3-/- oocytes from all follicle size groups (Fig. 4.1) (Ledent et al. 2005). Higher 
Gs levels in Gpr3
-/- oocytes could possibly explain the lower meiotic competence in these 
oocytes. However, this is unlikely to be the case, because in the absence of GPR3, all Gs resides 
in the plasma membrane, indicating that it is inactive (Ledent et al. 2005). When Gs is activated 
by GPR3 it translocates into the cytoplasm and is likely to be degraded, reflecting lower Gs 
levels in the Gpr3+/+ oocytes (Ledent et al. 2005). Gs levels did not increase in the oocytes from 
follicles of increasing size (Fig 4.1). This indicates that only genotype seems to alter Gs 
expression, and Gs is not a marker of the acquisition of oocyte meiotic competence.  
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Figure 4.1. Gs increases in expression in Gpr3-/- oocytes compared to Gpr3+/+ oocytes at all 
follicle sizes. Western blot for Gs in oocytes isolated from follicles of defined diameters, from 
the same ovary. 
 
Future Directions 
What additional markers can indicate Gpr3-/- oocytes are less meiotically competent compared to 
Gpr3+/+ oocytes? 
 The germinal vesicle break down (GVBD) time course is one way to analyze the ability 
of the oocyte to be able to resume meiosis and to be able to make conclusions about oocyte 
meiotic competence. However, there are other ways to test and support the conclusion that Gpr3-
deficient oocytes are less competent compared to Gpr3+/+. Staining oocytes with Hoechst or 
labeling for anti-tubulin can give insight about the structure and localization of chromatin and 
microtubules. It was found that incompetent oocytes have more diffused nuclear chromatin, 
unlike competent oocytes with condensed chromatin around the nucleous (Wickramasinghe, 
Ebert, Albertini 1991b). Also, microtubules are diminished in the cytoplasm of competent 
oocytes (Wickramasinghe, Ebert, Albertini 1991b). Lastly, higher levels of phosphorylation on 
centrosomes are in competent oocytes compared to incompetent oocytes (Wickramasinghe and 
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Albertini 1992). These nuclear and cytoplasmic markers can be applied to Gpr3-/- oocytes to 
analyze their state of meiotic competence. 
 
Are other cell cycle proteins, in addition to CDK1, differentially expressed in Gpr3-/- oocytes? 
 By specifically using the previous approach of systematically dissecting follicles of 
determined sizes, we can further study oocytes from these follicles for other cell cycle proteins 
between Gpr3+/+ and Gpr3-/- oocytes. As previously mentioned, prior studies have indicated a 
change in expression of WEE1B and CDC25B; however, they used mice of different ages and 
didn’t correlate this expression to the follicle size, making these proteins ideal to analyze in 
regards to follicle development. Also, phosphorylation status of CDK1 and Cyclin B have been 
indicated to change with regard to achieving meiotic competence, and can be further studied to 
better understand when these events are taking place with respect to follicle development, as well 
as to understand when kinases become active to phosphorylate these proteins.  
 
How are reduced CDK1 levels in Gpr3-/- oocytes resulting in a less competent oocyte? 
  From the data, it is evident that CDK1 is significantly reduced in Gpr3-/- oocytes, leading 
it to be hypothesized that this is the cause for the slower rate of meiotic resumption compared to 
Gpr+/+. It has been shown that an oocyte-specific deletion of Cdk1 results in fully-grown oocytes 
permanently arrested and unable to resume meiosis, contributing to mouse infertility (Adhikari et 
al. 2012). However, there are several downstream targets of CDK1 that can also possibly be 
differentially regulated in the absence of GPR3, contributing to an incompetent oocyte. For 
instance, CDK1 phosphorylates A-type lamins (lamin A/C) on Ser22 and Ser392 to promote the 
disassembly of the nuclear lamina during meiotic resumption (Heald and McKeon 1990; 
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Holaska, Wilson, Mansharamani 2002; Peter et al. 1990; Ward and Kirschner 1990). In 
conjunction to phosphorylating lamins, CDK1 also phosphorylates phosphatase PP1 at Thr320 
causing it to be inactive (Kwon et al. 1997; Wu et al. 2009). Inactivated PP1is unable to 
dephosphorylate lamin A/C, further contributing to a net phosphorylation of nuclear lamins 
initiated by CDK1 in meiotically competent oocytes (Figure 4.3) (Ceulemans and Bollen 2004). 
In the Gpr3-/- oocytes, it is not clear if the lower levels of CDK1 result in lamins not 
becoming phosphorylated, or perhaps there is not a sufficient amount of CDK1 to phosphorylate 
and inactivate PP1. Clearly CDK1 can’t sufficiently phosphorylate both lamins and PP1, as this 
results in GVBD, which is delayed in Gpr3-/- oocytes. To test the effect of reduced CDK1 
expression in Gpr3-/- oocytes, we can utilize the newly developed technique involving 
posttranslational protein degradation called Trim-Away (Clift et al. 2017). This method uses the 
antibody receptor and ubiquitin ligase, TRIM21 (Figure 4.2) (Clift et al. 2017).  
In overview, Gpr3-/- oocytes from early antral follicles will be used, as these had the most 
striking delay in GVBD compared to Gpr3+/+. The follicle-enclosed oocytes will be 
microinjected with RNA encoding the TRIM21 protein, which contains a GFP tag to ensure the 
RNA is translated (Figure 4.2) (Clift et al. 2017). After TRIM21 protein is expressed in the 
oocytes, antibody against PP1 will be microinjected into the same oocyte allowed for time to be 
translated. TRIM21 will recognize the antibody to PP1, ubiquitinate PP1, and tag it for 
degradation through the proteasome pathway (Figure 4.2). These now PP1-deficient Gpr3-/- 
oocytes will be released from their follicle and analyzed for a change in the rate of GVBD.  
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Figure 4.2. Schematic of the Trim-Away Technique. TRIM21 is drawn with an antibody 
receptor component conjugated with a ubiquitin ligase and GFP. Once an antibody against a 
protein of interest is introduced, TRIM21 will bind to the antibody-protein complex, ubiquitinate 
the protein, causing it to be endogenously degraded (Clift et al. 2017).   
 
If the rate of GVBD increased, this would suggest that CDK1 was able to phosphorylate 
lamins, but unable to phosphorylate PP1, resulting in it being active. Degrading PP1 in this case 
would remove the active PP1, allowing lamins to stay phosphorylated resulting in more GVBD 
(Figure 4.3). Conversely, if there is a similar rate of GVBD with and without PP1 degradation, 
this would indicate that CDK1 is unable to phosphorylate lamins, resulting in an oocyte that is 
less competent to resume meiosis (Figure 4.3). 
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Figure 4.3. Using Trim-Away to Degrade PP1 in incompetent Gpr3-/- Oocytes. It has been 
shown that CDK1 is downregulated in incompetent Gpr3-/- oocytes. By degrading PP1 it can be 
determined if the CDK1 present in these oocytes is sufficient enough to phosphorylate nuclear 
lamins, as indicated by GVBD.  
 
We have tested the Trim-Away approach in oocytes to degrade the highly expressed IP3 
receptor. Along with TRIM21 RNA, we microinjected an affinity purified antibody specific for 
the IP3 receptor (Runft, Watras, Jaffe 1999), or normal rabbit IgG. As shown in Figure 4.4, the 
protein was completely degraded by 2 hours after antibody microinjection. This leads us to 
believe this approach will work to degrade PP1 in oocytes. 
 
                                    
Figure 4.4. Depletion of IP3R in oocytes using Trim-Away. Oocytes were injected with RNA 
encoding TRIM21 and were subsequently injected with IgG or IP3 receptor antibody, and were 
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collected 2-2.5 hrs after antibody injection. 12 oocyte lysates were run per lane on this Western 
blot, which was probed with an anti-IP3 receptor antibody. U = uninjected control oocytes; IgG = 
IgG-injected oocytes; IP3R = IP3 receptor antibody-injected oocytes. 
 
Which genes are upregulated during the acquisition of meiotic competence? 
 Even though there are a few cell cycle proteins that can promote the acquisition of 
meiotic competence, it is not completely known if other genes can also be involved in this 
process. To identify the differential expression of genes during the acquisition of meiotic 
competence, RNAseq data can be analyzed between incompetent Gpr3+/+ oocytes from preantral 
follicles and competent Gpr3+/+ oocytes from antral follicles. The difference in gene expression 
from these two groups of oocytes can indicate those genes that are needed during oocyte growth 
to become competent. Also, RNAseq can be performed on Gpr3-/- oocytes from the preantral and 
antral follicle sizes and be compared with the data from Gpr3+/+ oocytes. This would indicate 
genes that are differential expression dependent on cAMP presence.  
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